Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
AAA, Andrew, appointed, arm, Asian, ATM, began, Beijing, Berkman, Boyce, chain, chemically, chicken, Cochran, contended, controversy, COPD, cow, customizable, cutting, cyclodextrin, Delaware, denying, departure, die, dispute, domestication, edge, Espinoza, exacerbation, exemption, expiry, faith, fifty, Foehr, fractional, global, good, headcount, highly, invasive, Jennifer, join, Kangchen, Korenberg, LGND, lieu, light, lump, Matthew, media, numerically, OABI, Objective, Octavio, OmniClic, OmniFlic, OmniTaur, Patel, percent, pertaining, pneumonia, pneumoniae, postmenopausal, preferred, President, prevailing, rat, rata, Reardon, recombinant, refund, renamed, repertoire, resolution, robust, Sanofi, Sarah, scalable, secondary, Secretary, shift, solubility, solution, Southeast, span, stability, Stifel, Sunil, symbol, ticker, tranche, Tribunal, underpaid, Vice, VWAP
Removed:
adult, alternative, American, arbitrator, assembled, assist, batoclimab, biologic, Black, cell, channel, China, combined, consummated, consummating, customary, delay, depression, developed, disrupt, employ, expertise, FDA, focal, focusing, fully, funded, fungal, governmental, initiate, intramuscular, ion, Jazz, kidney, large, larger, lead, leukemia, licensing, liver, lymphoblastic, monoclonal, muscle, myasthenia, NMPA, obtained, operate, opposition, patient, personnel, pivotal, postpartum, preliminary, proposed, recently, regimen, relationship, science, securing, seek, segmental, seizure, submission, submitted, tangible, targeted, targeting, therapy, treat, wasting, work, worldwide
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view